Overview
![](/assets/images/picto-drapeau-france-OnZXal1.png)
ABSTRACT
The features of miniaturized continuous-flow reactors enable them to overcome some of the limitations of conventional macrobatch reactors for chemical synthesis, with impressive results in both fundamental chemistry and production. After presenting the properties of fluidic reactors, this article describes their contribution to safety and their application in the control of toxic compounds on the one hand, and in the synthesis of active pharmaceutical ingredients on the other, with particular emphasis on the "autonomous miniature factory" aspect.
Read this article from a comprehensive knowledge base, updated and supplemented with articles reviewed by scientific committees.
Read the articleAUTHORS
-
Jean-Christophe MONBALIU: Professor - Center for Integrated Technology and Organic Synthesis (CiTOS), MolSys Research Unit, University of Liège, Allée du Six Août 13, B-4000 Liège (Sart Tilman), Belgium - Principal Investigator - WEL Research Institute, Avenue Pasteur, 6, 1300 Wavre, Belgium
-
Julien LEGROS: Research Director, CNRS - COBRA Laboratory, University of Rouen Normandy, Mont-Saint-Aignan, France
INTRODUCTION
The global events of the 2020s are leading the world to rethink certain models which, until recently, seemed irreplaceable. The COVID pandemic has shattered the economic patterns of certain manufactured products, among which the severe limit to the supply of fine chemicals, and therefore of active pharmaceutical ingredients (APIs), has been highlighted. This has led to severe shortages of strategic medicines, jeopardizing the ability of national healthcare systems to treat their citizens. Most of the so-called "industrialized" countries showed the limits of their industrial apparatus in this emergency situation. What's more, the Russian-Ukrainian conflict has exacerbated this situation, with an urgent need for rapid and radical change in the reorganization of manufacturing industry.
Since the early 2000s, the production of fine chemicals, such as APIs and their intermediates (most of which have fallen into the public domain), has been almost entirely relocated to distant countries, both for reasons of cost and lesser environmental and safety constraints, which is intrinsically linked to the production method for these compounds: macroscopic batch reactors. Indeed, the use of batch reactors means that, to produce more, their capacity has to be increased, which entails high investment and a large workforce, as well as significant safety constraints. This logic has led to the dismantling of chemical production facilities in many countries.
Unlike other sciences, which have revolutionized their concepts over the last few decades, organic synthesis (the cornerstone of drug manufacturing) has used more or less the same tools since the 1950s, and is still based on knowledge that is often empirical. In 2024, however, there is an alternative technology to synthesis in macrobatch reactors: miniaturized continuous-flow reactors. Where conventional production requires very large installations, continuous flow synthesis uses a production tool the size of a household appliance.
Exclusive to subscribers. 97% yet to be discovered!
You do not have access to this resource.
Click here to request your free trial access!
Already subscribed? Log in!
![](/assets/images/logo-eti-KGYj7ZH.png)
The Ultimate Scientific and Technical Reference
KEYWORDS
Fine chemicals | Miniaturized chemical plants | Miniaturized continuous flow reactors | Chemical engineering | Scale up | Factory 5.0
This article is included in
Green chemistry
This offer includes:
Knowledge Base
Updated and enriched with articles validated by our scientific committees
Services
A set of exclusive tools to complement the resources
Practical Path
Operational and didactic, to guarantee the acquisition of transversal skills
Doc & Quiz
Interactive articles with quizzes, for constructive reading
Miniaturized chemical flow plants
Bibliography
Directory
Manufacturers – Suppliers
Vapourtec : https://www.vapourtec.com/
Corning : https://www.corning.com/
Uniqsis : http://www.uniqsis.com/
...
Exclusive to subscribers. 97% yet to be discovered!
You do not have access to this resource.
Click here to request your free trial access!
Already subscribed? Log in!
![](/assets/images/logo-eti-KGYj7ZH.png)
The Ultimate Scientific and Technical Reference